"Hôpital médico-chirurgical, spécialisé tête et cou- ophtalmologie - neurologie - neurochirurgie - neuroradiologie interventionnelle - ORL - neuro imagerie - Urgences ophtalmologiques adultes/enfants -24H/24 - 7J/7 - Service Imagerie Médical - toutes les informations sur notre site web."

During the past decade, Fondation Rothschild; Service de Neurologie conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fondation Rothschild; Service de Neurologie" #1 collaborator was "Biogen" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fondation Rothschild; Service de Neurologie" are "Multiple Sclerosis" (2 trials), "CIDP" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Peripheral Neuropathy Associated With Anti-myelin Associated Glycoprotein Antibodies (Anti-MAG Neuropathy)" (1 trials). Many other conditions were trialed in "Fondation Rothschild; Service de Neurologie" in a lesser frequency.

Most popular intervention types in "Fondation Rothschild; Service de Neurologie" are "Other" (3 trials), "Drug" (2 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (2 trials), "CIDP treated (IVIG)" (1 trials), "Clinical assessment of peripheral nerve function" (1 trials), "Ocrelizumab 300 mg" (1 trials) and "Ocrelizumab 600 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fondation Rothschild; Service de Neurologie" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Fondation Rothschild; Service de Neurologie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Fondation Rothschild; Service de Neurologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fondation Rothschild; Service de Neurologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".